Human Umbilical Cord Mesenchymal Stem Cells to Treat Neuromyelitis Optica Spectrum Disorder (hUC–MSC–NMOSD): A Study Protocol for a Prospective, Multicenter, Randomized, Placebo-Controlled Clinical Trial

BACKGROUND: Neuromyelitis Optica spectrum disorder (NMOSD) is severe relapsing and disabling autoimmune disease of the central nervous system. Its optimal first-line treatment to reduce relapse rate and ameliorate neurological disability remains unclear. We will conduct a prospective, multicenter, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Xiao-Ying, Xie, Li, Cai, Yu, Zhang, Ying, Deng, Ye, Gao, Mei-Chun, Wang, Yi-Shu, Xu, Hui-Ming, Ding, Jie, Wu, Yi-Fan, Zhao, Nan, Wang, Ze, Song, Ya-Ying, Wang, Li-Ping, Xie, Chong, Li, Ze-Zhi, Wan, Wen-Bin, Lin, Yan, Jin, Hai-Feng, Wang, Kan, Qiu, Hui-Ying, Zhuang, Lei, Zhou, Yan, Jin, Yu-Yan, Ni, Li-Ping, Yan, Jia-Li, Guo, Quan, Xue, Jia-Hui, Qian, Bi-Yun, Guan, Yang-Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082633/
https://www.ncbi.nlm.nih.gov/pubmed/35547390
http://dx.doi.org/10.3389/fneur.2022.860083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082633/
https://www.ncbi.nlm.nih.gov/pubmed/35547390
http://dx.doi.org/10.3389/fneur.2022.860083

Ejemplares similares